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Xeroderma pigmentosum (XP) is a devastating disease 
associated with dramatic skin cancer proneness. XP cells 
are deficient in nucleotide excision repair (NER) of bulky 
DNA adducts including ultraviolet (UV)-induced muta-
genic lesions. Approaches of corrective gene transfer in 
NER-deficient keratinocyte stem cells hold great hope 
for the long-term treatment of XP patients. To face this 
challenge, we developed a retrovirus-based strategy to 
safely transduce the wild-type XPC gene into clonogenic 
human primary XP-C keratinocytes. De novo expression 
of XPC was maintained in both mass population and 
derived independent candidate stem cells (holoclones) 
after more than 130 population doublings (PD) in cul-
ture upon serial propagation (>1040 cells). Analyses of 
retrovirus integration sequences in isolated keratinocyte 
stem cells suggested the absence of adverse effects such 
as oncogenic activation or clonal expansion. Further-
more, corrected XP-C keratinocytes exhibited full NER 
capacity as well as normal features of epidermal differen-
tiation in both organotypic skin cultures and in a preclin-
ical murine model of human skin regeneration in vivo. 
The achievement of a long-term genetic correction of 
XP-C epidermal stem cells constitutes the first preclinical 
model of ex vivo gene therapy for XP-C patients.
  
IntroductIon
The mammalian epidermis is a squamous stratified epithelium 
endowed with a capacity of permanent renewal throughout life 
and fast regeneration upon accidental injury. Interfollicular epi-
dermal stem cells are located in the innermost layer (basal layer) 
of the epithelium. Although they divide infrequently in vivo, epi-
dermal stem cells can achieve more than 150 population doublings 
(PD) and generate a progeny of >1040 cells when cultivated under 
appropriate conditions in vitro.1 Clonal analyses have shown that, 
in vitro, the keratinocytes endowed with the highest proliferative 
potential generate large colonies whose progeny is composed of 
>95% clonogenic cells. These keratinocytes, known as holoclones, 
are thought to correspond to epidermal stem cells.2 Remarkably, 
cultured epidermal stem cells retain the ability to regenerate a 
fully differentiated epidermis when grafted back to an autologous 
donor as demonstrated by the successful treatment of thousands 
of severely burnt patients since the late 1970s.3,4 On this basis, it 
has been proposed that skin resurfacing using genetically cor-
rected epidermal stem cells could greatly contribute to the clinical 
treatment of some devastating monogenic skin diseases that still 
lack appropriate treatment. Recent advances reported by Mavilio 
and colleagues demonstrated the benefits of ex vivo corrective 
gene transfer in combination with skin grafting for patients suf-
fering from junctional epidermolysis bullosa.5
Xeroderma pigmentosum (XP) is one of those rare, life-threat-
ening disorders. XP patients are highly sensitive to sunlight expo-
sure and have a tremendous risk (2000×) of developing skin tumors 
in sun-exposed areas, mostly basal and squamous cell carcinomas, 
arising from epidermal keratinocytes, and malignant melanomas.6 
XP cells are deficient in nucleotide excision repair (NER), a versa-
tile DNA repair mechanism involved in the removal of bulky DNA 
adducts including ultraviolet (UV)-induced lesions such as cyclob-
utane pyrimidine dimers (CPD) and 6,4 pyrimidine- pyrimidone 
(6-4 PP). NER relies on the recognition of helix-distorting lesions 
followed by the assembly of a multiprotein machinery leading to 
(i) DNA unwinding around the lesion catalyzed by XPB and XPD 
helicases; (ii) excision of the DNA strand bearing the lesion thanks 
to the 5′ and 3′ endonuclease activities of XPF and XPG, respec-
tively; (iii) replicative DNA synthesis and ligation.7 The NER pro-
cess operates through two subpathways thought to differ only in 
the initial step of DNA damage recognition. In actively transcribed 
genes, stalling of RNA polymerase II at the DNA distortion initiates 
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the assembly of the repair complex (transcription-coupled repair). 
In contrast, the global genome repair subpathway is triggered by 
the recognition of bulky lesions in nontranscribed DNA by the 
XPC-HR23B-Centrin2 complex.8 Seven XP groups of genetic 
complementation (XP-A to XP-G) corresponding to gene-specific 
alterations of the NER pathway have been described. Persistence 
of UV-induced DNA damage in NER-deficient XP cells results in 
 elevated mutagenesis, eventually leading to the development of skin 
tumors in sun-exposed areas. Recent experimental evidence has 
suggested that UV-induced skin carcinomas may result from the 
accumulation of DNA damage in murine epidermal stem cells9,10 
but direct evidence in human cells deserves further investigations. 
Nevertheless, one can anticipate that NER deficiency in XP stem 
cells and/or progenitors is expected to play an essential role in skin 
cancer development. Protecting stem cells from the accumulation 
of DNA lesions thus appears as the cornerstone of any perennial 
anticancer approach for XP patients.
In the absence of any curative treatment for XP patients, man-
agement of the disease mainly involves strict avoidance of sun 
exposure and surgical resection of newly developed skin tumors. In 
most severe cases, excision of large portions of skin can be followed 
by reconstructive surgery using photo-protected skin autografts.11,12 
However, engrafted cells remain DNA repair-deficient and thus 
susceptible to UV-induced neoplastic transformation.13 Grafting 
genetically corrected skin in XP patients would certainly reduce 
the incidence of cancerous lesions as long as (i) skin grafts con-
tain a sufficient proportion of stem cells to allow lifelong renewal 
of the regenerated epidermis, (ii) all stem cells are functionally 
corrected, i.e., are protected against mutagenesis, (iii) safety assess-
ment excludes adverse effects such as oncogene activation linked 
to retroviral integration. XP group C (XP-C) is the best candidate 
for an ex vivo cutaneous gene therapy protocol since clinical traits 
of XP-C patients are mainly restricted to photo-exposed skin, gen-
erally without the neurological disorders that can be observed in 
other XP groups.14 In our previous attempt, however, we failed 
to obtain a sustained expression of XPC complementary DNA in 
XP-C primary keratinocytes, i.e., for more than 30 PD (ref. 15 and 
Arnaudeau, Chevallier and Magnaldo, unpublished results). To cir-
cumvent this limiting issue, we developed a safe, retroviral-based 
protocol based on immunoaffinity sorting of multiplying/trans-
duced primary XP-C keratinocytes. For the first time, our data 
demonstrate that (i) retrovirus-mediated wild-type XPC gene trans-
fer in XP-C primary keratinocytes fully restores DNA repair capac-
ity and cell survival properties after UV irradiation; (ii) corrected 
XP-C keratinocytes exhibiting the long-term growth potential of 
stem cells can be isolated in culture after retroviral transduction 
and non-antibiotic cell selection; (iii) transgene expression in stem 
cells persists sufficiently to ensure long-term protection against UV 
challenge after 130 PD; (iv) transduced XP-C keratinocytes can 
regenerate, both in vitro and in vivo, a differentiated epidermis with 
a normal capacity to repair UV-induced DNA lesions.
results
correction of the genetic defect responsible for the 
XP disease
Our first aim here was to assess the presence of stably corrected 
stem cells after retroviral transduction of primary keratinocytes 
populations isolated from healthy and non-photo exposed skin 
from XP-C patients. To allow purification of transduced cells, we 
constructed a Moloney murine leukemia virus-derived retroviral 
vector containing the bicistronic cassette CD24-IRES-XPC driven 
by the cytomegalovirus promoter (Supplementary Figure S1). 
CD24 is a small cell surface marker of postmitotic epidermal 
keratinocytes.16 We previously reported that ectopic expression of 
CD24 in clonogenic keratinocytes allows their immnunoaffinity-
based selection with subsequent enrichment in stem cells.17 Yet, 
as for other genodermatoses such as recessive junctional epider-
molyis bullosa,5 the presence of a sufficient number of stem kera-
tinocytes in patients’ cell cultures and their safe transduction and 
selection remained to be demonstrated.
Primary keratinocytes from three independent XP-C donors 
(XP373VI, XP521VI, and XP798VI) were infected with high-titer 
(1.2 × 109 infectious viral genome/ml) retroviral supernatants and 
purified by magnetic-activated cell sorting using a monoclonal 
CD24 antibody. No evidence of altered morphology or cytotox-
icity was observed after transduction and cell sorting (data not 
shown). Southern blot analysis demonstrated the presence of a 
4.7 kb fragment corresponding to the full-length proviral sequence 
in the genome of transduced cells (Supplementary Figure S1). 
Expression of CD24 and XPC proteins in control (WT), paren-
tal (XP-C), and transduced XP-C cells (XP-C+CD24-XPC) was 
assessed by indirect immunofluorescence labeling and western 
blotting (Figure 1a,b). In WT and XP-C keratinocytes, CD24 
was detected only at the periphery of stratified/differentiated cells 
(large cells); in contrast, exogenous CD24 was expressed at the 
membrane of transduced, clonogenic keratinocytes (small cells) 
from where it is normally absent16 (Figure 1a). Due to germinal 
mutations resulting in the production of a premature termina-
tion codon (Supplementary Table S1) and the use of an antibody 
raised against the carboxyterminal end of the protein, the XPC 
protein was not detected in XP-C keratinocytes. In contrast, all 
nuclei were positive in WT control cells as well as in transduced 
XP-C keratinocytes (Figure 1a). In transduced cells, levels of 
nuclear XPC were heterogeneous from one colony to another, sug-
gesting that the sorted population was polyclonal. Western blot-
ting analysis showed that the full-length XPC protein (XPC-FL, 
125 kDa) was expressed in WT and transduced XP-C keratino-
cytes, but could not be detected in parental XP-C keratinocytes 
(Figure 1b). Surprisingly, two additional bands migrating as ~110 
and ~100 kDa proteins, respectively, were also detected in trans-
duced XP-C keratinocytes, suggesting retrovirus-driven expres-
sion of shorter forms of the XPC protein (see discussion).
To assess the ability of transduced XP-C keratinoytes to per-
form NER, unscheduled DNA synthesis (UDS) was measured after 
UVB irradiation, as described15,18 (Figure 1c). In XP-C keratino-
cytes, the residual DNA repair capacity was low (10–15% com-
pared to WT keratinocytes), and almost no increase was observed 
after UVB irradiation. Conversely, transduced XP-C keratinocytes 
recovered dose-dependent levels of UDS in the range of two inde-
pendent NER-proficient strains of primary keratinocytes (about 
70 and 90% UDS recovery after the highest UVB dose compared 
to WT1 and WT2 strains, respectively).
The ability of transduced, NER-reverted keratinocytes to 
counteract lethal effects of UV irradiation was then assessed by 
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clonal analysis. In the absence of UV irradiation, colony-forming 
efficiencies (CFE) of WT, XP-C, and transduced XP-C keratino-
cytes ranged over 10–20%. After UVB irradiation, XP-C kerati-
nocytes showed markedly reduced survival levels when compared 
to WT keratinocytes (Figure 1d). In contrast, transduced XP-C 
keratinocytes exhibited UVB cell survival comparable to that of 
WT cells (Figure 1d). Altogether, these data demonstrate efficient 
reversion of the DNA repair defect and UV sensitivity of XP-C 
keratinocytes following transduction with the CD24-IRES-XPC 
retroviral vector.
long-term genetic correction of XP-c patient’s 
keratinocyte stem cells ex vivo
Successful gene therapy in rapidly renewing tissues requires efficient 
stem cell targeting, an essential prerequisite for long-term trans-
gene expression.19 In vitro clonogenic studies have demonstrated 
that holoclones, which corresponds to epidermal stem cells in 
vitro, generate large colonies with a smooth perimeter (LSP) when 
seeded at clonal density on feeder cells.2 The presence of geneti-
cally corrected holoclones among transduced XP-C keratinocytes 
was thus assessed by clonal analysis and serial propagation. We 
isolated 32 candidate holoclones from the XP798VI+CD24-XPC 
mass population; all of them expressed the XPC protein, although 
at variable levels (Supplementary Figure S2). The  long-term 
growth potential of three clones (clone 4, 8, and 25) with XPC-FL 
protein levels in the range of control cells (Figure 2a) was analyzed. 
The three clones as well as the corrected mass population were 
serially propagated for more than 140 days and achieved more 
than 140 PD (Figure 2b). These data unambiguously demonstrate 
the presence of true stem cells within the transduced population. 
Whether the reverted population and the derived holoclones 
expressed XPC-FL in the long-term was assessed by western blot 
analysis. In the reverted mass population subjected to serial prop-
agation, the total amount of XPC was clearly reduced from 85 PD, 
although it was still detected after 110 PD (Figure 2c). In clone 8, 
XPC expression was roughly stable up to 70 PD before decreasing 
and being stably maintained at a low but detectable level until 110 
PD (end of western blot experiment). In clone 4 and in clone 25, 
XPC expression was only decreased after 100 and 90 PD, respec-
tively (Figure 2c).
To determine whether the decrease of XPC expression mea-
sured in the reverted mass population could be due to a loss of 
transduced cells, we isolated eight clones from the mass popula-
tion after 120 PD. The full-length CD24-IRES-XPC cassette (4.7 kb) 
was detected in genomic DNA from all clones (Supplementary 
Figure S2), but expression of the XPC protein was uniformly 
weak in those eight clones (Supplementary Figure S2). Together, 
these data suggested that upon serial propagation clonal restric-
tion could have occurred in favor of clones expressing low levels 
of XPC.
To demonstrate long-term functional protection against UV 
radiation, cell survival of transduced keratinocytes that were 
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Figure 1 restoration of XPc expression, uV-cell survival and nucleotide excision repair in transduced XP-c keratinocytes. (a) Immunofluorescence 
analysis of XPC (green) and CD24 (red) expression in WT (WT1) and XP-C (XP521VI) keratinocytes before (XP-C) and after (XP-C+CD24-XPC) retrovi-
ral transduction and CD24 selection. DAPI was used to stain nuclei. (b) Western blot analysis of WT (1: WT1; 2: WT2), XP-C (3: XP373VI; 4: XP521VI; 
5: XP798VI), and transduced XP-C keratinocytes (6: XP373VI+CD24-XPC; 7: XP521VI+CD24-XPC; 8: XP798VI+CD24-XPC). Anti-XPC and anti-CD24 
antibodies were used as probes; anti-GAPDH antibody was used as a loading control. (c) Determination of nucleotide excision repair (NER) efficiency 
after UVB irradiation by unscheduled DNA synthesis (UDS) at the indicated doses. Percent repair efficiency is determined by the ratio of the average 
number of grains in a strain to the average number of grains in WT#1 cells at 1,500 J/m2 (100%). Data are represented as mean ± SEM of at least 
two independent experiments. (d) UV survival curves of WT, XP-C, and transduced XP-C strains after UVB irradiation at the indicated doses. GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase; NER, nucleotide excision repair; UDS, unscheduled DNA synthesis.
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propagated over 10, 80, and 140 PD was assessed by clonal analy-
sis after a single UV-solar simulated radiation (SSR) exposure 
(4,000 J/m2 UVB + 41,300 J/m2 UVA) (Figure 2d). At this dose, 
survival of WT and XP-C keratinocytes was about 50 and 10%, 
respectively. In the reverted mass population, decreased XPC 
expression in cells serially propagated over 140 PD was accompa-
nied by a significantly higher (about 40%) cell mortality; resistance 
of transduced keratinocytes at 140 PD was nevertheless three-
fold higher than that of parental XP-C cells. In contrast UV-cell 
survival of clone 4 at 135 PD remained similar to that of control 
(WT) keratinocytes. Since holoclone 4 can be expanded over 140 
PD and can still generate LSP colonies after 120 PD (Figure 3), it 
can be considered as a bona fide stem cell with stable genetic and 
 phenotypic correction.
safety of the genetic correction in individual 
clonogenic epidermal cells
To assess the safety of integration events in transduced keratino-
cytes, we performed a genome-wide analysis of the proviral inte-
gration sites in 10 clones isolated from the corrected XP798VI mass 
population after 20 PD. Libraries of vector-genome junctions were 
generated by linker-mediated (LM) nested PCR, and sequenced 
to saturation. This approach allowed unambiguous mapping of 
33 independent integrations in genomic DNA and confirmed the 
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Figure 2 Presence of corrected stem cells in transduced XP-c 
 keratinocytes cell populations. (a) Western blot analysis of XPC expres-
sion in holoclones (C8, C4, and C25) isolated from CD24-XPC-transduced 
XP798VI keratinocytes (M, corrected mass population). WT1, positive 
control; XP798VI, parental XP-C keratinocytes. Anti-GAPDH antibody was 
used as a loading control. (b) Cumulative cell doublings of CD24-XPC-
transduced XP798VI keratinocytes (XP798VI+CD24-XPC (mass), open 
diamonds) and holoclones C4 (black triangles), C8 (black squares), and 
C25 (black cross). (c) Western blot analysis of XPC expression in CD24-
XPC transduced XP798VI keratinocytes (mass) and its derived holoclones 
C8, C4, and C25 after the indicated population doublings (PD 1–120). 
(d) Survival of CD24-XPC-transduced XP798VI keratinocytes (mass) 
and its derived holoclone (clone 4) after exposure to a single UV-solar 
simulated radiation (UV-SSR, 4,000 J/m2 UVB + 41,300 J/m2 UVA) dur-
ing long-term serial propagation. Data are represented as mean ± SEM 
of two independent experiments. GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase; PD, population doublings.
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polyclonality of the transduced mass population (Supplementary 
Table S2). As expected for γ-retroviruses, about 30% of the integra-
tions occurred ≤30 kb upstream or downstream of 30 genes, and 
15% were located at a distance ≤10 kb from transcriptional start 
sites. Twelve integrations (36%) were classified as intergenic and 
11 (33%) were within the transcribed portion of referenced genes 
(Supplementary Tables S2 and S3). To investigate the putative 
emergence of specific clones during serial propagation, analysis 
of the proviral integration sites was also performed in nine clones 
isolated from the corrected XP798VI mass population after 120 
PD. Fifteen independent integrations were found in these clones, 
among which five were also present in clones isolated after 20 PD 
(Supplementary Table S2). Since these integration sites were asso-
ciated with different events at each time point, we concluded that 
no particular integration event was clonally selected.
Generation of genetically corrected skin ex vivo and 
in vivo
The ability of corrected XP-C keratinocytes to complete epider-
mal morphogenesis was then assessed in ex vivo organotypic skin 
cultures and after grafting onto athymic mice. In organotypic 
skin cultures, gene-corrected cells retained full stratification and 
 differentiation potential (Figure 4a, Histology). As expected, the 
XPC protein was not detected in epidermis regenerated from 
both parental and CD24-GFP-transduced XP-C keratinocytes 
(Figure 4a, XPC protein). In WT epidermis, the XPC protein was 
preferentially detected in the basal layer, whereas in epidermis 
regenerated from CD24-XPC-transduced XP-C keratinocytes, XPC 
was detected at variable levels in all (basal and suprabasal) nuclei 
(Figure 4a, XPC protein). Organotypic skin cultures were exposed 
to a single dose of UV-SSR (1,600 J/m2 UVB + 17,000 J/m2 UVA) 
and DNA repair efficiency was measured by  immunostaining of 
CPD lesions at various times after UV exposure (Figure 4a, CPD 
lesions and Figure 4b). Immediately after irradiation, CPD lesions 
were detected in all keratinocyte nuclei irrespective of the type of 
epidermis. Twenty-four hours after UVB irradiation, most nuclei 
remained positive in XP-C epidermis, whereas fewer CPD lesions 
were detected in WT, XP-C+CD24-GFP, and XP-C+CD24-XPC 
epidermis (Figure 4a,b). Five days after irradiation, about 75% 
CPD lesions persisted in all layers of XP-C and XP-C+CD24-GFP 
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Figure 4 restoration of proficient dnA repair in genetically corrected organotypic skin cultures. (a) Histological staining (HES, hematoxylin, 
eosin, and safran) shows that transduced XP-C (XP798VI) keratinocytes (XP-C+CD24-XPC) regenerate an epidermis with appropriate features of 
stratification and differentiation. XP-C keratinocytes transduced with pCMMP CD24-IRES-GFP retrovirus were used as a control (XP-C+CD24-GFP). 
XPC protein expression was revealed by immunofluorescence staining (XPC, red). The NER efficiency after a single UV-SSR exposure (1,600 J/m2 UVB 
+ 17,000 J/m2 UVA) was assessed by indirect immunofluorescence staining of CPD DNA lesions at the indicated time points (CPD lesions, brown). 
The dash line delimits the dermal–epidermal junction. Bar, 50 µm. (b) Quantification of CPD repair in organotypic skin cultures. For each sample, 
CPD-positive cells were counted on four independent representative fields and their number was expressed with respect to the epidermis surface 
area, as estimated using ImageJ software. (c) After p53 immunolabeling, quantification of p53-positive cells was performed as described in b. Mean 
values obtained from each epidermis were compared to mean values in WT (*) or corrected XP-C epidermis (#) at the same time point. **/##P < 0.001; 
*/#P < 0.01. All XP-C keratinocytes were from patient XP798VI. CPD, cyclobutane pyrimidine dimers; NER, nucleotide excision repair.
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epidermis. In contrast, >95% of lesions were removed in WT 
 epidermis and only 15% were still detectable in XP-C+CD24-XPC 
epidermis (Figure 4a,b).
In accordance, the P53 protein, which expression is stabilized 
in the presence of DNA lesions, rapidly accumulated in the nuclei 
of basal keratinocytes of all samples 24 hours after irradiation 
(Figure 4c). Five days after irradiation, the number of P53-positive 
cells had returned to basal levels in WT and XP-C+CD24-XPC 
epidermis, whereas it remained elevated in NER-deficient epider-
mis (XP-C and XP-C+CD24-GFP).
Recently a skin-humanized mouse model of XP-C was 
achieved upon engraftment of bioengineered skin regener-
ated from XP-C patients cells onto immunodeficient mice.20 
Following this approach we generated mice engrafted either 
with WT, XP-C+CD24-GFP or XP-C+CD24-XPC keratinocytes 
(Figure 5c), Histology. As previously observed in XP-C skin-
humanized mice,21 animals engrafted with corrected XP-C cells 
presented normal skin architecture (Figure 5c, Histology and 
Supplementary Figure S3).
Immunostaining of XPC using our polyclonal mouse anti-
body on the grafts section was not reliable (see Material and 
Methods). Nevertheless, the full-length CD24-IRES-XPC tran-
script (4.7 kb) could be detected in the corrected skins 12 weeks 
after grafting (Figure 5a). Real-time quantitative-PCR analyses 
revealed persistence of high levels of XPC messenger RNA in 
corrected  (CD24-IRES-XPC) grafts compared to control (WT) 
and  mocktransduced (CD24-IRES-GFP) grafts (Figure 5b).
Human skin grafts were then submitted to a single UVB 
exposure at a dose equivalent to twice the biological efficient 
dose, based on previously described criteria.22 Two hours after 
UV irradiation, CPD lesions were detectable in all nuclei of the 
regenerated skins and persisted in an amount virtually identical 
24 hours later (Figure 5c, CPD lesions). However, owing to some 
background staining, reliable quantification of CPD lesions could 
not be performed as for organotypic skin cultures (Figure 4); nev-
ertheless, we could definitely determine that 4 days after UV expo-
sure (96 hours), CPD lesions were completely eliminated from 
WT and XP-C+CD24-XPC regenerated skins whereas numerous 
CPD-positive nuclei could still be detected in XP-C+CD24-GFP 
epidermis (Figure 5c, CPD lesions). These data indicated that 
genetically corrected XP-C keratinocytes recovered full NER cap-
city in the three-dimensional context of skin in vivo.
dIscussIon
We report herein the first long-term genetic correction of epider-
mal stem cells from NER-deficient/cancer-prone XP-C patients. 
Until now, most approaches of retroviral/lentiviral mediated-
 corrective gene transfer in XP cells have been limited to fibro-
blasts.23–26 However, since most skin tumors arise from epidermal 
keratinocytes, cutaneous gene therapy for XP patients must rely on 
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Figure 5 restoration of normal dnA repair capacity in vivo. (a) RT-PCR analysis of the full-length CD24-IRES-XPC transcript (4.7 kb) in XP-C+CD24-
GFP (lane 1) and XP-C+CD24-XPC (lane 2) regenerated skins in vivo, 12 weeks after grafting. (b) Real-time quantitative-PCR analysis of XPC mRNA 
levels in WT, XP-C+CD24-GFP and XP-C+CD24-XPC regenerated skins in vivo, 12 weeks after grafting. GAPDH and PPIA mRNA levels were quantified 
in each sample for normalization. (c) Histological appearance of WT, XP-C+CD24-GFP, and XP-C+CD24-XPC epidermis was revealed by HES staining 
8 weeks after grafting. The NER efficiency was assessed after labeling of CPD lesions by indirect immunofluorescence at the indicated times to assess 
the ability to repair CPD DNA lesions after a single UVB exposure (3,360 J/m2). The dash line indicates the dermal–epidermal junction. Bar, 50 µm. 
Histological aspect of the grafts at each time point following UV exposure is shown in Supplementary Figure 3. CPD, cyclobutane pyrimidine 
dimers; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HES, hematoxylin, eosin, and safran; mRNA, messenger RNA; NER, nucleotide excision 
repair; RT-PCR, reverse transcriptase-PCR.
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the stable genetic correction of XP keratinocyte stem cells. Since 
prospects of skin grafting require the complete elimination of 
cancer-prone cells, and thus the selection of genetically corrected 
keratinocytes, here we used a strategy allowing the safe sorting of 
transduced keratinocyte stem cells.17 Using this method, primary 
keratinocytes from three independent XP-C patients were trans-
duced with a retroviral vector containing the CD24-IRES-XPC 
cassette. The choice of a retroviral vector was dictated by a much 
higher efficiency of transduction of human primary epidermal 
keratinocytes compared to lentiviral vectors (data not shown). In 
primary keratinocytes, other studies reported either similar effi-
ciency of lentiviruses and γ-retroviruses,27 or a threefold higher 
efficiency of retroviruses over lentiviruses.28 γ-retroviruses are 
also superior over lentiviruses for transducing the collagen VII 
complementary DNA in human and dog cells from individual suf-
fering from recessive dystrophic epidermolysis bullosa.29,30
In the three strains studied here, as in about 95% XP-C patients, 
the XPC protein could not be detected, presumably due to non-
sense-mediated mRNA decay of transcripts containing in-frame 
premature stop codons.31 Unexpectedly, expression of the full-
length (125 kDa) XPC protein in transduced XP-C keratinocytes 
was accompanied by the expression of two shorter proteins of 
~100 and 110 kDa. The XPC coding sequence bears two in-frame 
AUG codons (positions +457 and +685, respectively, downstream 
the bona fide initiation codon (+106)). Translation initiation from 
these codons could theoretically generate proteins of 823 (XPC 
(118–940), ~110 kDa] and 747 (XPC (194–940), ~100 kDa] amino 
acids, respectively. In 1992, Legerski et al. reported the cloning of a 
human XPC complementary DNA lacking the 117 first amino acids 
(XPC (118–940)]; expression of this protein in immortalized XP-C 
cells restored normal UDS levels and UV survival properties.32 This 
protein presumably corresponds to the 110 kDa protein observed 
in our transduced cells. Whether XPC (194–940), is functional and 
retains the capacity to interact with other DNA repair proteins such 
as OGG1 and XPA7,33,34 is not known yet. However, the absence of 
cytotoxicity, the full recovery of UDS and cell survival after UVB 
irradiation in transduced XP-C keratinocytes suggest that this 
shorter XPC form neither acts as a dominant negative regulator 
of NER nor noticeably modifies cell behavior. For safety reasons, 
improved retroviral constructs containing an internal promoter 
instead of the IRES sequence (as described in ref. 29) are being 
developed and should avoid the production of these XPC isoforms.
In contrast to hematopietic stem cells that can be enriched 
a priori by immunologic sorting from bone marrow samples, 
there is no reliable means (except the selection of holoclones) 
to isolate interfollicular keratinocyte stem cells in culture before 
genetic manipulation. A major objective here was thus to assess 
safe and successful genetic correction of XP-C keratinocyte stem 
cells. Our results indicate that (i) mass populations of genetically 
corrected XP-C keratinocytes contain clones with the morpho-
logical characteristics of holoclones and (ii) candidate holoclones 
could be individually propagated ex vivo for more than 140 PD, 
which definitively demonstrates the presence of stem cells in the 
transduced population. A second essential question concerned 
the sustainability of corrective gene expression in transduced 
XP-C keratinocyte stem cells. Our previous attempts showed 
that retroviral-mediated expression of the XPC protein in XP-C 
keratinocytes was limited to 6–7 weeks (<30 PD),15 presumably due 
to antibiotic selection of transduced cells.19 Our CD24-selection 
procedure yielded a much better sustainability of XPC expression, 
yet the latter was decreased in the very long term (>85 PD) in 
the mass population after serial propagation. In individual clones 
derived from this mass population, the amount of XPC protein(s) 
was roughly stable up to 70 (clone 8), 100 (clone 4), and 90 (clone 
25) PD, respectively; then, expression of all three forms of XPC 
was reduced, although it was still clearly detectable after 100 PD 
(Figure 2). Since the average proviral copy number was dimin-
ished by about 35% between 20 and 120 PD (Supplementary 
Figure S2), a progressive selection of clonogenic cells bearing less 
copies of the proviral genome could account for the decrease of 
XPC levels in the transduced mass culture. XPC is a DNA binding 
protein thought to permanently scan the chromatin for the pres-
ence of bulky DNA adducts.8 Inappropriately elevated levels of 
XPC could thus interfere with the replication and/or transcription 
processes and result in slower growth of cells expressing high lev-
els of XPC. Finally, we cannot rule out that silencing of the trans-
gene, through methylation of the provirus regulatory sequences,35 
or post-translational modification of XPC protein stability, could 
also contribute to the decrease of XPC expression, in particular in 
isolated holoclones. Importantly, after 130 PD, residual amount 
of the XPC protein was still sufficient to confer protection against 
UV to the transduced mass population, as well as to holoclones. 
Considering that human epidermis contains ~1010 cells and is 
entirely renewed every month (i.e., about 1,000 renewals in 80 
years), less than 45 PD from one stem cell should be largely suffi-
cient to produce the cell progeny required for complete epidermal 
regeneration throughout life (about 1013 cells). Since we were able 
to isolate stably transduced stem cells in which functional expres-
sion of XPC was maintained over 100 PD, pools of transduced 
holoclones carefully chosen after mapping of retroviral insertion 
sites36 should be largely sufficient for lifelong replacement of a 
dilapidated skin area by a fully sun-resistant counterpart.
Beyond protection against UV irradiation, an important ques-
tion was to assess their capacity to generate a normal epidermis 
in organotypic skin cultures and after grafting on immunodefi-
cient mice. Due to its transcriptional control by the hybrid long 
terminal repeat-cytomegalovirus promoter, XPC was expressed 
in all living layers of the epidermis regenerated from transduced 
XP-C keratinocytes, whereas it was found mostly in the basal layer 
of control (WT) reconstructed epidermis, as in human skin.37 
Organotypic skin cultures and skin grafts regenerated from trans-
duced keratinocytes exhibited normal features of proliferation, 
stratification, and differentiation (data not shown), suggesting 
that pan-epidermal XPC expression had no detectable impact on 
epidermal homeostasis.
Although, irrespective of the host species of antibodies, 
we failed to reliably detect the XPC protein in situ on sections 
from skin-humanized mice (see Materials and Methods), long-
term presence and expression of XPC in corrected skin could be 
verified by real-time quantitative-PCR 12 weeks after grafting. 
Importantly, in both organotypic skin cultures and skin regen-
erated in vivo from reverted XP-C keratinocytes (8 weeks after 
grafting), complete elimination of CPD DNA lesions could be 
observed by 96 hours following a single UVB irradiation. Thus, 
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in a 3D context, the expression of XPC in both basal and supra-
basal epidermal layers remained compatible with normal rates of 
DNA repair by NER in corrected XP-C epidermis. Together with 
efficient NER, the absence of prolonged nuclear accumulation of 
P53 in corrected XP-C epidermis suggests recovery of a normal 
cellular response to UV-induced DNA damage.
In further experiments it will be essential to determine whether 
corrected XP-C epidermal cells are also protected in the long-term 
from UV-induced tumorigenesis. Using recombinant adenoviruses, 
Marchetto et al. have shown that in vivo delivery of human XPA 
complementary DNA to Xpa-mutant mice prevented UVB-induced 
squamous cell carcinoma development.26 However, as the use of ade-
noviral vectors in clinical trials is hampered by the strong immune 
response they elicit in the host,38 lentiviruses and Moloney murine 
leukemia virus-derived retroviruses currently remain the most suit-
able vectors for optimal transduction of primary keratinocytes.5,30,39 
Here, safety assessment of retroviral integration sites did not reveal 
clonal expansion of cells containing specific integration events after 
serial propagation in vitro. Although a clonal restriction might 
still occur in vivo, Kolodka et al. suggested that the number of PD 
required to maintain the grafted epidermis for 12 weeks is probably 
not sufficient to generate this restriction in vivo.40 In accordance, 
Mavilio and colleagues reported the absence of clonal selection 4 
months after grafting corrected keratinocytes in a patient suffering 
from junctional epidermolysis bullosa.5 This first successful clinical 
trial of ex vivo cutaneous gene therapy was based on a conventional 
MoMLV retroviral vector.5 As described in the latter study,5 the 
only accurate way to identify transduced stem cells is to isolate and 
propagate clonogenic cells in vitro. Such an approach may appear 
as a limitation in the frame of clinical applications but the present 
study shows that appropriate and highly controlled culture condi-
tions give excellent results. Then, in the case of XP patients, a first 
attempt would be to graft genetically corrected epidermal sheets at 
the place of surgically resected tumors. Prior such clinical applica-
tion, we aim at further minimizing the potential adverse effects of 
insertional mutagenesis and oncogene activation41 using self-inacti-
vating vectors in which the transgene would be under the control of 
the endogenous XPC promoter.29
MAterIAls And Methods
Skin biopsies and cell culture. All XP-C patients presented a marked 
 photosensitivity and were unrelated (Supplementary Table S1). XP-C 
skin biopsies from non-photo exposed sites (buttock) were obtained with 
the patients’ or parents’ written informed consent in accordance with the 
declaration of Helsinki.
Keratinocytes were seeded at a density of 4,000 cells/cm2 in complete 
F12 Adenine DMEM (cFAD) medium, on a feeder layer of lethally X-ray–
irradiated 3T3-J2 fibroblasts as described.42 Cells were cultured at 37 °C in a 
10% CO2 atmosphere.
Retroviral production and transduction. Infectious retroviral particles 
pseudotyped with the vesicular stomatitis virus glycoprotein were produced 
following triple transfection of helper plasmids and the proviral genome 
(Supplementary Figure S1) in 293T cells as described.43 RV particles were 
resuspended in serum-free medium (Invitrogen, Cergy-Pontoise, France). 
Keratinocyte were seeded at a density of 8,000 cells/cm2 and were trans-
duced with concentrated RV supernatants (1.2 × 109 vg/ml) in serum-free 
medium for 16 hours as described.17 (Sigma-Aldrich, St Louis, MO). They 
were then refed with cFAD medium until reaching 80–90% confluence.
Magnetic-activated cell sorting CD24 cell sorting. Keratinocytes were dis-
sociated and incubated for 20 minutes at 4 °C with CD24 monoclonal anti-
body (ABL9; Immunotech, Luminy, France) in cold phosphate-buffered 
saline containing 0.5% bovine serum albumin, 2 mmol/l EDTA. After two 
washes, they were incubated for 15 minutes at 4 °C with goat anti-mouse 
IgG-coupled microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), 
and then sorted on magnetic-activated cell sorting as described.17
Irradiation sources and procedures. UVB irradiation was performed 
using a Philips TL20W/12 fluorescent tube as described.44 UV-SSR using 
a 1000 W Xenon lamp equipped with a dichroic mirror (Oriel, Les Ulis, 
France) filtered by UG5 (2 mm) and WG 320 (1.5 mm) filters (Schott, 
Clichy, France) was performed as described.45 Organotypic skin cultures 
were exposed without medium to 18,600 J/m2 UV-SSR (1,600 J/m2 UVB 
+ 17,000 J/m2 UVA).
Western blot analysis. Proteins in 8 mol/l urea buffer were separated on 
10% SDS–polyacrylamide gels, transferred onto a polyvinyl difluoride 
membrane (GE Healthcare, Saclay, France) and probed using mouse mono-
clonal XPC antibody (dilution 1/1,000; Abcam, Cambridge, UK), CD24 
monoclonal antibody (ALB9; Immunotech; dilution 1/400) or GAPDH 
monoclonal antibody (clone 9484; Abcam; dilution 1/2,000). Blots were 
revealed using electrochemiluminescence reagents (GE Healthcare).
Southern blot. Genomic DNA (20 µg) was digested overnight with AgeI/
EcoRV restriction enzymes (Roche, Meylan, France) to release the full-
length CD24-IRES-XPC cassette (4.7 kb) (Supplementary Figure S1). 
Digested DNA was separated on a 0.7% agarose gel, transferred to a nylon 
membrane (Hybond; GE Healthcare) and hybridized with a [32P]-labeled 
XPC-specific probe obtained by PCR amplification (XPC: 5′AAAACACG
ATGATAATATGGCC/5′GCAGAGTAAATAGCAAATCTCC).
UDS analysis. DNA repair after UVB irradiation was followed by [3H]
thymidine incorporation as described.18,44 The mean number of grains per 
nucleus was obtained by counting at least 60 non-S phase nuclei for each 
UV dose. All UDS experiments were performed at least twice.
Real-time quantitative-PCR. Biopsies from regenerated skins (~0.2 cm2) 
were excised 12 weeks after grafting. Samples were crushed using Lysing 
Matrix D beads and FastPrep 24 device (MP Biomedicals, Illkirch, France). 
Total RNA extraction was then performed using RNeasy Mini Kit (Qiagen, 
Hilden, Germany). Reverse transcription was performed using Advantage 
RT for PCR kit (Clontech, Saint-Germain-en-Laye, France) according 
to the manufacturer’s protocol. The full-length CD24-IRES-XPC cassette 
was amplified using 5′TAATCCGGATCCTCTAGAGC/5′CCCTCAAAG
TAGACGG-CATC. Real-timequantitative-PCR was performed accord-
ing to the manufacturer instructions using Hs01104212_m1 primer set 
for XPC, Hs99999905_m1 for GAPDH, and Hs999999904_m1 for PPIA 
(Peptidylpropyl isomerase A/cyclophilin A).
Cell survival analysis. Keratinocytes were grown in 60-mm dishes. After 
UV exposure, cells were dissociated and seeded at clonal density (17 cells/
cm2) onto lethally γ-irradiated 3T3-J2 feeders. After 12 days, keratinocyte 
colonies were fixed in 3.7% formaldehyde in phosphate-buffered saline and 
colored by 1% rhodamine B (Sigma-Aldrich). The relative cell survival was 
calculated as follow: (number of colonies obtained after UV irradiation/
number of colonies obtained from non-irradiated cells) × 100.
Clonal analysis and long-term serial propagation of individual clones. 
Clonal types were determined as described2,44: (i) large colonies (∅>4mm) 
with a LSP; (ii) small (∅<1mm) terminally differentiated colonies; (iii) 
intermediate (1<∅<4mm) wrinkled colonies (W). LSP colonies were 
individually trypsinized; one-fourth of each clone was transferred into 
a 100-mm culture dish to perform secondary clonal analysis and three-
fourths of each clone was replated for serial propagation and further analy-
sis. Corrected XP-C mass population and selected clones were serially 
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passaged during 22 weeks (1 passage per week). Proteins were prepared 
every 2 weeks. PD was calculated as follow: PD = (log N/N0)/log2, where 
N0 represents the number of colony-forming cells plated and N the total 
number of cells obtained at passage.
Organotypic skin cultures. Detailed procedure was as described.46 
Keratinocytes overlying the dermal equivalent (lattice) were then incu-
bated for 7 days at 37 °C, 5% CO2, immersed in the culture medium, before 
being raised at the air–liquid interface for 8 days. Each condition was per-
formed in duplicate. After SSR exposure, samples were immediately har-
vested or maintained for 24 hours or 5 days at the air–liquid interface, and 
then processed for analyses.
In vivo regeneration of genetically engineered human epidermis. A fibrin 
matrix populated with live fibroblasts was used as the dermal component of 
the bioengineered skin following the procedure previously described.21 WT, 
gene-corrected or uncorrected XP-C human keratinocytes (0,5–1 × 106 
cells/well) were then seeded on the fibrin matrix to form the epidermal layer 
of the bioengineered skin. When confluent, bioengineered skins were man-
ually detached from tissue culture wells and grafted onto immunodeficient 
mice. All animal studies have been approved by Centro de Investigaciones 
Energéticas Medioambientales y Tecnológicas’s (CIEMAT) institutional 
review board and all experimental procedures were conducted according 
to European and Spanish laws and regulations. Animals were housed in 
pathogen-free conditions, in individually ventilated type II cages, with 25 
air changes per hour and 10 KGy γ-irradiated soft wood pellets as bedding.
Immunostaining analysis. Immunolabeling of XPC and CD24 proteins 
were performed on cells or on air-dried 5-µm cryosections using mouse 
polyclonal XPC antibody47 (dilution 1/400) and CD24 monoclonal anti-
body (ALB9; Immunotech; 1/50). Note that the murine polyclonal XPC 
antibody generated an unacceptable background in human skin grafted in 
mice. We thus failed to reliably detect the XPC protein in human skin sec-
tions after grafting. Detection of thymine dimers on cryosections was car-
ried out as previously described, using mouse monoclonal H3 antibody 
(1/300; Sigma-Aldrich).22 For detection of p53 and thymine dimers on 
formalin-fixed paraffin-embedded sections, mouse monoclonal p53 (1/50; 
Diaclone, Besançon, France) and KTM53 (1/1,000; Kamiya Biomedicals, 
Seattle, WA) antibodies were used. Staining was revealed using a biotin/
streptavidin detection kit (Vector Laboratories, Burlingame, CA).
Analysis of retroviral integration sites. Integration sites were cloned by 
LM-PCR, as described.5 Genomic DNA was digested with MseI and PstI, 
and ligated to an MseI double-strand linker. LM-PCR was performed with 
nested primers specific for the LTR and the linker. PCR products were 
shotgun cloned by the TOPO TA cloning kit (Invitrogen) into libraries of 
integration junctions, which were sequenced to saturation. Sequences were 
mapped onto the human genome by the BLAT genome browser (UCSC 
Human Genome Project Working Draft, May 2004; http://www.genome.
ucsc.edu).
Statistical analysis. Results are expressed as means ± SD. Mean values 
were compared using two-tailed Student’s t-test. P values < 0.01 were con-
sidered statistically significant.
suPPleMentArY MAterIAl
Figure S1. Southern analysis of provirus integration into the host 
genome.
Figure S2. XPC expression in independent keratinocyte clones at low 
and high population doublings.
Figure S3. Histological features of in vivo regenerated skin after UV 
exposure.
Table S1. Patients and cells characteristics.
Table S2. Complete list of proviral integrations in corrected clones 
isolated after 20 and 120 population doublings.
Table S3. Distribution of proviral integration sites.
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